- £106.43m
- £94.75m
- £32.16m
- 75
- 18
- 40
- 37
REG - Diaceutics PLC - Awarded UK Research Institute Grant Funding of £1m
AnnouncementREG - Diaceutics PLC - Total Voting Rights
AnnouncementREG - Diaceutics PLC - Expansion of US Commercial Activities
AnnouncementREG - Diaceutics PLC - Capital Markets Webinar
AnnouncementREG - Diaceutics PLC Danske Bank A/S - Holding(s) in Company
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Board Change Update
AnnouncementREG - Diaceutics PLC - Issue of Share Options/PDMR Shareholdings
AnnouncementREG - Diaceutics PLC - Cancellation of Share Premium Account
AnnouncementRCS - Diaceutics PLC - Diaceutics Announces Key Leadership Appointment
AnnouncementREG - Diaceutics PLC - Holding(s) in Company
AnnouncementREG - Diaceutics PLC - Block Listing Return
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Board Changes
AnnouncementREG - Diaceutics PLC - H1 2024 Results - Continued Performance & Growth
AnnouncementREG - Diaceutics PLC - Notice of Results & Presentations
AnnouncementREG - Diaceutics PLC - Appointment of Nominated Adviser and Broker
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Diaceutics Launches Enhanced Rare-Disease Offering
Announcement